<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.2-a.3'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//medicinacardiometabolica.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/31/eeuu-243-metoclopramida/</loc>
  <lastmod>2026-08-31T16:22:09Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Metoclopramida (Reglan): para qué sirve, dosis, efectos secundarios y precio (2026)</news:title>
   <news:publication_date>2026-08-31T16:22:09Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/31/esc-2026-munich-ensayos-estatinas-trigliceridos-presion-insuficiencia-cardiaca/</loc>
  <lastmod>2026-08-31T11:37:38Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>ESC 2026 Múnich: los ensayos que cambian la práctica en estatinas, triglicéridos, presión arterial e insuficiencia cardíaca</news:title>
   <news:publication_date>2026-08-31T11:37:38Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/31/mbe-semana-07-razon-prevalencia-poisson/</loc>
  <lastmod>2026-08-31T11:32:04Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Razón de Prevalencia con Poisson Robusto: El Método Correcto</news:title>
   <news:publication_date>2026-08-31T11:32:04Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/30/pulso-parvus-et-tardus-clave-estenosis/</loc>
  <lastmod>2026-08-30T22:17:06Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Pulso parvus et tardus: clave de estenosis aórtica</news:title>
   <news:publication_date>2026-08-30T22:17:06Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/30/eeuu-242-mounjaro-riesgo-cardiovascular/</loc>
  <lastmod>2026-08-30T16:18:18Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Mounjaro aprobado por la FDA para reducir infartos y derrames: qué cambia, dosis y precio (2026)</news:title>
   <news:publication_date>2026-08-30T16:18:18Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/30/esc-2026-radar-cardiometabolico/</loc>
  <lastmod>2026-08-30T12:06:31Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>ESC 2026: Radar Cardiometabólico 30 Ago 2026</news:title>
   <news:publication_date>2026-08-30T12:06:31Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/30/rehabilitacion-cardiaca-2026-esc-indicaciones-clase-i-prescripcion-ejercicio/</loc>
  <lastmod>2026-08-30T11:16:12Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Rehabilitación cardíaca 2026 ESC: primera guía europea, indicaciones clase I y cómo prescribir el ejercicio en consulta</news:title>
   <news:publication_date>2026-08-30T11:16:12Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/29/pulso-arterial-tecnica-examen/</loc>
  <lastmod>2026-08-29T22:14:29Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Pulso arterial: técnica de examen y características</news:title>
   <news:publication_date>2026-08-29T22:14:29Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/29/guia-esc-2026-insuficiencia-cardiaca/</loc>
  <lastmod>2026-08-30T12:07:19Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Guía ESC 2026 de Insuficiencia Cardíaca</news:title>
   <news:publication_date>2026-08-29T18:27:38Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/29/eeuu-241-pantoprazol/</loc>
  <lastmod>2026-08-29T16:19:27Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Pantoprazol (Protonix): para qué sirve, dosis, efectos secundarios y precio (2026)</news:title>
   <news:publication_date>2026-08-29T16:19:27Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/29/perfil-hepatico-alterado-cardiometabolico-fib4-derivacion/</loc>
  <lastmod>2026-08-29T11:17:14Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Perfil hepático alterado en el paciente cardiometabólico: enfoque diagnóstico, FIB-4 y umbrales de derivación</news:title>
   <news:publication_date>2026-08-29T11:17:14Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/29/guia-esc-2026-enfermedad-cardiovascular-renal-cronica/</loc>
  <lastmod>2026-08-30T12:08:04Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Guía ESC 2026 de enfermedad cardiovascular y renal crónica</news:title>
   <news:publication_date>2026-08-29T10:11:20Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/08/29/quinta-definicion-universal-infarto-miocardio-2026/</loc>
  <lastmod>2026-08-29T06:06:05Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Quinta Definición Universal del Infarto de Miocardio 2026</news:title>
   <news:publication_date>2026-08-29T06:06:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>